The mRNA expression of SULF1 has been reported to inhibit tumor growth and angiogenesis in breast cancer cell lines [29] and also altered cisplatin-treatment response in ovarian cancer [15]. This evidence concerns the gene SULF1 and ovarian carcinoma.